Skip to content

CV Sciences, Inc.

CVSI· OTCCore metricsCIK 1510964

Pharmaceutical preparations552 peers

Close
Oct 5, 2026
Market cap
$2.36M
235.69M shares
Filings
434
$3.03M
Q3 2026−12.2% FY25 yoy
-$93.00K
Q3 2026N/M FY25 yoy
$377.00K
Q3 2026N/M FY25 yoy
$174.00K
Q3 2026derivedN/M FY25 yoy
$0.00
Q3 2026N/M FY25 yoy
$308.00K
Q3 2026−38.8% FY25 yoy
$2.36M
—
0.2×
1.0×
-8.02%
—

Twelve months to Sep 30, 2026 · derived

Price

$0.0166.67%$0.02since Dec 16, 2025
Oct 5, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$13.79MFY 2025
$53.70M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$13,789,000reported
FY 20242024-12-31$15,705,000reported
FY 20232023-12-31$16,004,000reported
FY 20222022-12-31$16,205,000reported
FY 20212021-12-31$20,048,000reported
FY 20202020-12-31$24,429,000reported
FY 20192019-12-31$53,696,000reported
FY 20182018-12-31$48,244,000reported
FY 20172017-12-31$20,679,000reported
FY 20162016-12-31$11,060,636reported
FY 20152015-12-31$11,529,402reported
FY 20142014-12-31$10,190,667reported

Segments

Segments
Revenue by Segments, FY2019 to FY2020FY2019Consumer Products Segment · FY2019 · $53.70MFY2020Consumer Products Segment · FY2020 · $24.43M
LineFY2020ShareChange
Consumer Products Segment$24.43M100%−54.5%
Specialty Pharmaceutical Segment$0.00——
Total$24.43M

From the 10-K filed Mar 19, 2021CVSI

Pharmaceutical preparations

CV Sciences, Inc. is the 161st largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR